YouGov plc (YOU)
London Stock Exchange · UK · prices in GBX · close of 27 Oct 2026
Key indicators
| Last close | GBX 278.80 |
|---|---|
| 52-week range | 135.40 – 319.40 |
| Return, 1 month / 3 months | +5.9% / +14.4% |
| Return, 1 year / 3 years | +11.5% / −66.3% |
| Trend | Uptrend |
| RSI (14) | 52 |
| Volatility (1 year) | 45.0% |
| Worst drawdown (1 year) | -46.1% |
| Average daily value traded | 140.36M GBX |
| Dividend yield | 3.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
YouGov is a market research and data analytics company based in London. It gathers opinions and behaviour through online panels and surveys, then turns the results into reports and data services for clients. Its customers include businesses, media organisations, public bodies and brands that want to understand what people think and how they act. The company works across many countries and covers topics such as politics, consumer habits, brands and public affairs.
The shares are listed on the London Stock Exchange in UK under the code YOU, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
YouGov plc (YOU) trades on the London Stock Exchange in UK. It last closed at GBX 278.80 on 27 October 2026.
Its price-based Market X-Ray is 66 out of 100 (a fair price profile), ranking 864 of 3,788 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 11.5% and over the last three months it rose 14.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 84 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 22.4% | ||
| From 52-week high | -9.0% | ||
| Momentum | 77 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 14.4% | ||
| 6-month return | 49.7% | ||
| 12-month return, skipping the last month | 5.3% | ||
| Stability (higher is calmer) | 29 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 45.0% | ||
| Worst drawdown, 1 year (smaller is calmer) | -46.1% | ||
| Liquidity | 91 · Strong | Trades actively. | |
| Average daily value traded | 140.36M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 49 · Weak | Dividend is small or irregular. | |
| Dividend yield | 3.3% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.1% |
|---|---|
| 1 month | +5.9% |
| 3 months | +14.4% |
| 6 months | +49.7% |
| 1 year | +11.5% |
| 3 years | −66.3% |
| 5 years | −76.9% |
Signals
| 50-day / 200-day average | 270.52 / 227.86 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 12.83 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 27 Nov 2025 | GBP 0.0925 |
| 28 Nov 2024 | GBP 0.0900 |
| 30 Nov 2023 | GBP 0.0875 |
| 1 Dec 2022 | GBP 0.0700 |
| 2 Dec 2021 | GBP 0.0600 |
| 3 Dec 2020 | GBP 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.